ARCS Australia Welcomes Release of NSW Innovation Blueprint 2035

31 March 2025

ARCS Australia Ltd, the peak body representing life sciences professionals in the medtech and pharmaceutical sectors, strongly supports the release of the NSW Innovation Blueprint 2035. The Blueprint outlines a long-term, strategic vision for NSW as a global leader in innovation and recognises the critical role of the life sciences sector in delivering health, economic and social benefits. With a focus on advanced manufacturing, clinical trials, vaccine technologies, and commercialisation, the Blueprint aligns closely with ARCS Australia's mission to build workforce capability and support the growth of innovative businesses across the therapeutic goods sector.

More

ARCS Statement on the 2025–26 Federal Budget

27 March 2025

ARCS Australia welcomes the 2025–26 Federal Budget and acknowledges its implications for our members working to advance innovation in healthcare across the medtech and pharmaceutical sectors.

More

ARCS Launches Clinical Trial Service Provision Position Paper at 2024 ARCS Conference following 2023 Sydney Summit

18 June 2024

On 22 November 2023, ARCS orchestrated a pivotal summit focusing on the ICH-GCP E6(R3) renovation, emphasising the power of collaboration for successful implementation.

More

Interest Area Webinar (Clinical Research)

01 July 2025

Interest Area Webinar (Medical Operations)

03 July 2025

Mastering USA Pharmaceutical regulation for the Australian Landscape

11 July 2025

This advanced level workshop is about the USA Regulatory Framework